Clinical data | |
---|---|
Trade names | Flutenal |
Other names | UR-105; Triamcinolone acetonide metembonate; 4,4'-Methylene-bis((9α-fluoro-11β,21-dihydroxy-16α,17α-isopropylidenedioxypregna-1,4-diene-3,20-dione)3-methoxy-2-naphthoate); 21,21'-[Methylenebis[(2-methoxy-1,3-naphthalenediyl)- carbonyloxy]]bis[9α-fluoro-11β-hydroxy-16α,17α-[(1-methylethylidene)- bis(oxy)]pregna-1,4-diene-3,20-dione |
Routes of administration | Topical [1] |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard ( EPA) | |
ECHA InfoCard | 100.054.209 |
Chemical and physical data | |
Formula | C73H78F2O16 |
Molar mass | 1249.408 g·mol−1 |
3D model ( JSmol) | |
| |
|
Flupamesone (brand name Flutenal), also known as triamcinolone acetonide metembonate, is a synthetic glucocorticoid corticosteroid which is marketed in Spain. [2] [3] [4] [1] It is a dimer of a C21 ester of triamcinolone acetonide. [2] [3] [1]